Sangui BioTech International Inc – Strategy, SWOT and Corporate Finance Report

Sangui BioTech International Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Sangui Biotech International Inc (Sangui Biotech), formerly Citadel Investment System, Inc, is a pharmaceutical company that develops novel and proprietary pharmaceuticals, medical products and cosmetics. Sangui Biotech's product portfolio includes artificial oxygen carriers, nano formulations for the regeneration of skin, wound pads and wound spray. It also markets wound dressing products to support wound healing process in the name of chitoskin. The company develops oxygen carriers that can transport oxygen in acute and chronic conditions such as arterial blockage or anemia following injury, surgery, or other causes in humans. It markets the products in European countries, and Mexico through its subsidiary, and network of distribution partners. Sangui Biotech is headquartered in Witten, Nordrhein-Westfalen, Germany.

Scope

Detailed information on Sangui BioTech International Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Sangui BioTech International Inc in the form of a SWOT analysis

An in-depth view of the business model of Sangui BioTech International Inc including a breakdown and examination of key business segments

News about Sangui BioTech International Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Sangui BioTech International Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Sangui BioTech International Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Sangui BioTech International Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

WNDM Medical Inc

Johnson & Johnson

Derma Sciences Inc

Bristol-Myers Squibb Co

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 - About the Company 5

Sangui BioTech International Inc - Key Facts 5

Sangui BioTech International Inc - Key Employees 6

Sangui BioTech International Inc - Key Employee Biographies 7

Sangui BioTech International Inc - Major Products and Services 8

Sangui BioTech International Inc - History 9

Sangui BioTech International Inc - Company Statement 10

Sangui BioTech International Inc - Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2 Company Analysis 12

Company Overview 12

Sangui BioTech International Inc - Business Description 13

R&D Overview 13

Sangui BioTech International Inc - Corporate Strategy 14

Sangui BioTech International Inc - SWOT Analysis 15

SWOT Analysis - Overview 15

Sangui BioTech International Inc - Strengths 15

Sangui BioTech International Inc - Weaknesses 16

Sangui BioTech International Inc - Opportunities 17

Sangui BioTech International Inc - Threats 18

Sangui BioTech International Inc - Key Competitors 19

Section 3 Company Financial Ratios 20

Financial Ratios - Capital Market Ratios 20

Financial Ratios - Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios - Interim Ratios 24

Financial Ratios - Ratio Charts 25

Section 4 Company’s Lifesciences Financial Deals and Alliances 26

Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

Sangui BioTech International Inc, Recent Deals Summary 28

Section 5 Company’s Recent Developments 29

Nov 15, 2018: Sangui BioTech International: In the first three months of fiscal year 2019 29

Jul 25, 2018: Sangui BioTech International: Financial Results for the year 2018 30

May 04, 2018: Sangui BioTech International: fiscal year 2018 financial results 31

Jul 18, 2017: Sangui Bio announces Revenues in fiscal year 2017 32

Feb 24, 2017: Sangui Bio announces Sales in the first half year 33

Jan 12, 2017: Sangui Bio announces Revenues in the first half-year 34

Section 6 Appendix 35

Methodology 35

Ratio Definitions 35

About GlobalData 39

Contact Us 39

Disclaimer 39

List of Tables

List of Tables

Sangui BioTech International Inc, Key Facts 5

Sangui BioTech International Inc, Key Employees 6

Sangui BioTech International Inc, Key Employee Biographies 7

Sangui BioTech International Inc, Major Products and Services 8

Sangui BioTech International Inc, History 9

Sangui BioTech International Inc, Subsidiaries 11

Sangui BioTech International Inc, Key Competitors 19

Sangui BioTech International Inc, Ratios based on current share price 20

Sangui BioTech International Inc, Annual Ratios 21

Sangui BioTech International Inc, Annual Ratios (Cont…1) 22

Sangui BioTech International Inc, Interim Ratios 24

Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

Sangui BioTech International Inc, Recent Deals Summary 28

Currency Codes 35

Capital Market Ratios 35

Equity Ratios 36

Profitability Ratios 36

Cost Ratios 37

Liquidity Ratios 37

Leverage Ratios 38

Efficiency Ratios 38

List of Figures

List of Figures

Sangui BioTech International Inc, Performance Chart (2014 – 2018) 23

Sangui BioTech International Inc, Ratio Charts 25

Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports